Are loopholes endangering Poland’s healthcare?

Add bookmark
Pharma IQ
Pharma IQ
06/14/2016

As Poland announces plans to create a British-style NHS, a recent paper has proposed that one priority should be to address the potential blurred boundaries between public bureaucracies, politicians and industry providers such as pharmaceutical companies.Although the EU controls the approval process for new medicines, individual member states decide which to prioritise and subsidise. Research published in the British Journal of Sociology suggests that Poland’s pricing and reimbursement poli...
To continue reading this story get free access

RECOMMENDED